Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Clinical Epidemiology|February 21, 2012
The incentive to publish negative studies: how beta-blockers and depression got stuck in the publication cycleHendrika J Luijendijk, Xander Koolman
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 19, 2021
Evolocumab's Long-Term Mortality Risk Unclear Due to Shortened Follow-Up of FOURIERFolkert H van Bruggen, Hendrika J Luijendijk
Journal of the American Medical Directors Association|September 12, 2007
Nurses' and nursing assistants' recognition of depression in elderly who depend on long-term careKarel G Brühl, Hendrika J Luijendijk, Martien T Muller
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|January 23, 2024
The prognosis of delirium in older outpatientsDaisy Wp Quispel-Aggenbach, Sytse U Zuidema, Hendrika J Luijendijk
BMC Medical Research Methodology|September 24, 2020
Assessing risk of bias: a proposal for a unified framework for observational studies and randomized trialsHendrika J Luijendijk, Matthew J Page, Huibert Burger, et al.
Pharmacoepidemiology and Drug Safety|November 26, 2015
Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic reviewHendrika J Luijendijk, Niels C de Bruin, Tessa A Hulshof, et al.
CNS Drugs|September 2, 2019
Subjective Versus Objective Outcomes of Antipsychotics for the Treatment of Neuropsychiatric Symptoms Associated with DementiaEline J Vredeveld, Tessa A Hulshof, Sytse U Zuidema, et al.
British Journal of Clinical Pharmacology|December 21, 2007
Determinants of chronic benzodiazepine use in the elderly: a longitudinal studyHendrika J Luijendijk, Henning Tiemeier, Albert Hofman, et al.
Frontiers in Pharmacology|March 11, 2020
Large Sample Size Fallacy in Trials About Antipsychotics for Neuropsychiatric Symptoms in DementiaTessa A Hulshof, Sytse U Zuidema, Sarah I M Janus, et al.
Pageof 4